search

Active clinical trials for "Hypertension"

Results 3051-3060 of 5863

Combined Rg3-enriched Korean Red Ginseng and American Ginseng in the Management of Hypertension...

Diabetes Mellitus Type 2Hypertension

The study is a combined Phase-I like (safety) and Phase-II like (efficacy) double blind randomized placebo controlled trial. The objective is to investigate whether the combination of AG and Rg3-enriched Korean Red ginseng added to conventional medical treatment are effective and safe in the long-term management of high blood pressure while managing type 2 diabetes. Eighty-five subjects with type 2 diabetes and concomitant high blood pressure (key inclusion criteria: HbA1c ≥ 6.5%- ≤ 8.0%) will be recruited for the study.

Completed24 enrollment criteria

Short Course Terlipressin for Control of Acute Variceal Bleeding

HemorrhageEsophageal Varices1 more

The purpose of this study is to determine whether 24 hours of Terlipressin is as effective as 72 hours of Terlipressin in preventing re-bleed once esophageal variceal bleed has been controlled with endoscopic therapy (variceal band ligation or sclerotherapy) in low to moderate risk variceal bleed patients and hence can save cost and may decrease length of hospital stay especially in the I.C.U or high dependency units.

Completed10 enrollment criteria

A Study to Evaluate the Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled...

Hypertension

This study is designed to provide additional efficacy and safety data for a treatment strategy based on the combination valsartan with amlodipine in hypertensive patients previously treated with monotherapy and remaining uncontrolled. A naturalistic approach will be taken comparing two different doses, i.e. 160mg of valsartan with amlodipine 5mg and 10mg with possible addition of HCTZ

Completed8 enrollment criteria

Cilnidipine Effect on High Blood Pressure and Cerebral Perfusion in Ischemic Stroke Patients With...

HypertensionStroke

The purpose of this study is to compare the effect of cilnidipine (a calcium channel blocker) and losartan (an angiotensin II receptor blocker) on cerebral blood flow (CBF) and blood pressure in hypertensive patients with a previous ischemic stroke.

Completed4 enrollment criteria

The Effects of Cilnidipine on Metabolic Syndrome Improvement

HypertensionMetabolic Syndrome X

Abnormalities of glucose, insulin and lipoprotein metabolism are common in patients with hypertension, and these metabolic abnormalities are reported to be related to insulin resistance. Therefore, whenever treating such patients, antihypertensive agents that may have the added effect of improving insulin resistance should be selected. CinalongTM (Cilnidipine) is expected to improve metabolic syndrome as well as insulin resistance by its dual effects on L and N-type calcium (Ca) channels. In this study, the researchers investigate the effects of CinalongTM on insulin resistance and other metabolic related factors.

Completed8 enrollment criteria

Trial of Telmisartan 80 mg/HCTZ 12.5 mg and Telmisartan 40 mg/HCTZ 12.5 mg in Patients With Hypertension...

Hypertension

The objective of this trial is to assess the safety and efficacy of 52 weeks of open-label treatment with the fixed dose combination of telmisartan 80 mg plus HCTZ 12.5 mg and telmisartan 40 mg plus HCTZ 12.5 mg in patients with essential hypertension.

Completed9 enrollment criteria

SPP100 Dose Finding Study in Japan

Hypertension

This study will evaluate the efficacy of SPP100 in lowering blood pressure in patients with essential hypertension.

Completed8 enrollment criteria

Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension

Essential Hypertension

This study is to assess the safety and efficacy of an add-on treatment algorithm with olmesartan, hydrochlorothiazide and amlodipine in patients with mild to moderate hypertension.

Completed8 enrollment criteria

BREATHE 5-OL: Tracleer (Bosentan) in Patients With Pulmonary Arterial Hypertension Related to Eisenmenger...

Pulmonary Arterial Hypertension

This 6-month open label study will evaluate the long term safety of bosentan (via oxygen saturation) and efficacy (exercise capacity) in patients who have completed the BREATHE-5 study (PAH related to Eisenmenger physiology). Treatment duration is 6 months.

Completed13 enrollment criteria

A Study of the Efficacy and Safety of Nebivolol Added to Existing Antihypertensive Treatment in...

Hypertension

The purpose of this study was to contrast the efficacy and safety of 3 dose levels of nebivolol vs. placebo, when added to a patient's existing antihypertensive medication(s) for 3 months, in patients with mild to moderate hypertension

Completed3 enrollment criteria
1...305306307...587

Need Help? Contact our team!


We'll reach out to this number within 24 hrs